Category: Include on Menu
-
Insulet Reports Second-Quarter Revenue Growth as Full-Year U.S. Omnipod Outlook Is Lowered
The diabetes device maker exceeded second-quarter revenue guidance but reduced its full-year U.S. Omnipod sales growth forecast as it continues scaling in the type 2 diabetes market. Key Investor Takeaways Why PODD Stock Is in Focus Insulet (NASDAQ:PODD) reported second-quarter 2026 revenue of $801.7 million, up 23.5% from a year earlier and above the high…
-
AMD falls after Musk says SpaceX will exclusively use Nvidia AI chips
Advanced Micro Devices (NASDAQ:AMD) shares dropped more than 6% in early trading on Wednesday after Elon Musk revealed that SpaceX plans to source its artificial intelligence processors exclusively from Nvidia, overshadowing AMD’s stronger-than-expected quarterly earnings. The announcement weighed heavily on investor sentiment despite another quarter of record revenue and upbeat guidance from the semiconductor company.…
-
SpaceX slides as heavy AI investment overshadows strong quarterly results
SpaceX (NASDAQ:SPCX) shares dropped more than 12% in early trading on Wednesday after investors focused on the company’s soaring artificial intelligence spending, despite quarterly revenue exceeding expectations and management unveiling ambitious long-term growth plans. The decline followed the company’s first earnings report since its high-profile public listing in June, with investors expressing concern over the…
-
Chipotle rebounds after Minnesota clears restaurant chain in salmonella investigation
Chipotle Mexican Grill (NYSE:CMG) rose around 3.5% in pre-market trading on Wednesday after Minnesota health officials said they have no ongoing concerns about the company following a recent salmonella outbreak investigation. The rebound follows Tuesday’s 9.72% decline, the stock’s largest one-day fall in approximately nine months, as investors reacted to concerns over the foodborne illness…
-
AZN rebounds after report dismisses AstraZeneca-Bristol Myers merger speculation
AstraZeneca (NASDAQ:AZN) shares climbed around 6% on Wednesday after Reuters reported that there are “no discussions” between the company and Bristol Myers Squibb (NYSE:BMY) regarding a potential merger, contradicting recent speculation that had unsettled investors. The report eased concerns surrounding a deal that, if completed, would have created a pharmaceutical group valued at close to…
-
Disney shares rise after earnings beat despite slight revenue shortfall
Walt Disney Co. (NYSE:DIS) advanced nearly 5% in pre-market trading on Wednesday after reporting third-quarter adjusted earnings that comfortably exceeded analysts’ expectations, even though quarterly revenue came in slightly below forecasts. Investors welcomed the stronger profitability and the company’s decision to increase its share repurchase programme. Profit outperforms Wall Street forecasts Disney reported adjusted earnings…
-
Eli Lilly shares climb after stronger revenue outlook driven by obesity drugs
Eli Lilly (NYSE:LLY) rose more than 5% in pre-market trading on Wednesday after the pharmaceutical company increased its full-year revenue guidance, supported by continued strong demand for its blockbuster diabetes and weight-loss treatments. The revised outlook outweighed an earnings-per-share miss for the second quarter, as investors focused on accelerating sales growth and improved profitability expectations.…
-
Uber shares slip as third-quarter earnings outlook disappoints investors
Uber Technologies (NYSE:UBER) traded lower in pre-market trading on Wednesday after issuing third-quarter earnings guidance that came in below Wall Street expectations, despite reporting solid second-quarter operating performance. The weaker outlook overshadowed stronger-than-expected gross bookings during the latest quarter and renewed investor focus on the company’s investment plans. Third-quarter EPS forecast misses consensus Uber expects…
-
Shopify shares surge after strong Q2 results and upbeat outlook
Shopify (NASDAQ:SHOP) soared in pre-market trading on Wednesday after delivering second-quarter results that comfortably exceeded Wall Street expectations, with strong revenue growth, higher profitability and an optimistic outlook for the months ahead. Shares jumped around 26% before the opening bell as investors welcomed accelerating momentum across the company’s core business. Revenue and earnings beat expectations…
-
Kraft Heinz beats Q2 estimates and lifts 2026 outlook
Kraft Heinz (NASDAQ:KHC) traded slightly lower in pre-market trading on Wednesday despite reporting second-quarter results that exceeded market expectations and improving its full-year outlook. The food manufacturer posted earnings per share of $0.56, ahead of analysts’ forecast of $0.53. Revenue reached $6.26 billion, surpassing the consensus estimate of $6.11 billion. Organic sales remain under pressure…